Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still’s disease from sepsis

OBJECTIVE: To identify potential biomarkers to distinguish adult-onset Still’s disease (AOSD) from sepsis. METHOD: We recruited 70 patients diagnosed with AOSD according to the Yamaguchi criteria, 22 patients with sepsis, and 118 age-matched controls. Serum levels of 40 cytokines were analyzed using...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Tomohiro, Sumiyoshi, Remi, Furukawa, Kaori, Sato, Shuntaro, Migita, Kiyoshi, Shimizu, Toshimasa, Umeda, Masataka, Endo, Yushiro, Fukui, Shoichi, Kawashiri, Shin-ya, Iwamoto, Naoki, Ichinose, Kunihiro, Tamai, Mami, Nakamura, Hideki, Origuchi, Tomoki, Nonaka, Fumiaki, Yachie, Akihiro, Kondo, Hideaki, Maeda, Takahiro, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206754/
https://www.ncbi.nlm.nih.gov/pubmed/32381117
http://dx.doi.org/10.1186/s13075-020-02200-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206754/
https://www.ncbi.nlm.nih.gov/pubmed/32381117
http://dx.doi.org/10.1186/s13075-020-02200-4

Ejemplares similares